ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
The Need for a Multidisciplinary Approach for Successful High-Risk Pulmonary Embolism Treatment.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary embolism is a common cause of morbidity and mortality in the United States. A nonspecific clinical presentation makes it challenging to diagnose, and management varies significantly depending on a risk-benefit assessment, the patient's current clinical status, and institutional practices. Case Presentation: Multidisciplinary appraisal led to differing use of tissue plasminogen activator (tPA) infusion for 2 patients at intermediate-risk for pulmonary embolism. Both cases demonstrated favorable outcomes and improved right ventricular function after treatment. One patient underwent systemic tPA infusion and demonstrated resolution of pulmonary hypertension and symptoms after 24 hours. A second patient received localized tPA infusion for 24 hours and had a marked decrease in clot burden and pulmonary artery pressure gradient. Conclusions: These cases illustrate the variety and complexity of management of patients with intermediate-risk pulmonary embolism and highlight the role institutional pulmonary embolism response teams may have in these scenarios.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.